FibroBiologics Inc. Uncategorized Contracts & Agreements
8 Contracts & Agreements
- Description of registrants securities (Filed With SEC on February 29, 2024)
- Engagement Letter between FibroBiologics, Inc. and Maxim Group LLC dated April 24, 2023 (Filed With SEC on January 22, 2024)
- Agreement Regarding Right of First Negotiation dated January 20, 2023 (Filed With SEC on November 28, 2023)
- IP Transfer Agreement between SpinalCyte, LLC and FibroBiologics, LLC, dated as of May 17, 2021 (Filed With SEC on November 28, 2023)
- Intellectual Property Cross-License Agreement dated as of May 17, 2021, between SpinalCyte LLC and FibroBiologics, LLC (Filed With SEC on November 28, 2023)
- Agreement Regarding Right of First Negotiation dated January 20, 2023 (Filed With SEC on November 7, 2023)
- IP Transfer Agreement between SpinalCyte, LLC and FibroBiologics, LLC, dated as of May 17, 2021 (Filed With SEC on November 7, 2023)
- Intellectual Property Cross-License Agreement dated as of May 17, 2021, between SpinalCyte LLC and FibroBiologics, LLC (Filed With SEC on November 7, 2023)